• Home
  • About US
  • Contact Us
  • Privacy Policy
  • Terms of Use

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • March 2022
  • February 2022
  • January 2022
  • November 2019

Categories

  • Auto
  • Business
  • Climate & Earth
  • Coronavirus
  • Crypto
  • Entertainment
  • Happiness Basket
  • India
  • Learn | Unlearn | Relearn
  • Lifestyle
  • Politics
  • Research Discoveries
  • Science & Technology
  • Sports
  • Trending
  • Video
  • World
  • Home
  • About US
  • Contact Us
  • Privacy Policy
  • Terms of Use
Read Selective
  • World
  • Politics
  • India
  • Business
  • Entertainment
  • Lifestyle
  • Auto
  • Crypto
  • Coronavirus
  • Happiness Basket
  • Research Discoveries
  • Research Discoveries

Placenta-Derived Nasal Spray Shows Promise Against Alzheimer’s Disease

  • November 15, 2026
(Credit: Image provided by University of Texas Medical Branch)

A nasal spray made from placenta stem cells cut harmful amyloid buildup by more than half in the brains of Alzheimer’s mice and improved their memory performance, according to a new study from Italian researchers. The same treatment also protected human brain cells grown from Alzheimer’s patients’ own skin samples, offering two separate layers of evidence for an approach that could reshape how the disease is treated.

Behind the spray are tiny fluid-filled packets called extracellular vesicles, naturally released by stem cells from the amniotic membrane of human placentas. These packets act like tiny messengers, carrying genetic instructions and proteins that communicate with other cells. When researchers sprayed them into the noses of mice bred to develop Alzheimer’s-like brain changes, the packets traveled to the hippocampus, the brain region most responsible for memory, where both neurons and the brain’s resident immune cells absorbed them.

What happened next, reported in the journal Translational Neurodegeneration, is the real story. Female mice treated with the vesicles performed better on memory tests, showed sharply less amyloid buildup, and had immune cells that shifted from an aggressive, inflamed state to a calmer one. Researchers then tested the same vesicles on brain cells grown in a lab dish from the skin cells of actual Alzheimer’s patients. Those human cells were protected from the damage the disease usually causes.

How a Nasal Spray Delivers Alzheimer’s Treatment to the Brain
Before testing whether the treatment worked, scientists had to confirm it could even reach the right place. They isolated the packets from placenta stem cells, checked their size (mostly between 50 and 200 nanometers, far smaller than a single human cell), and confirmed they carried the right protein markers to count as genuine vesicles. Six separate batches came from six different placental donors, lowering the odds that results depended on one unusual sample.

After tagging the vesicles with a glowing dye and spraying them into mouse noses, researchers found evidence of them in every part of the hippocampus within hours. Neurons and microglia alike had absorbed the material, proof that a simple nasal spray could get therapeutic cargo past the barrier that normally keeps most substances out of the brain.

Female mice in the study carry genetic changes that cause Alzheimer’s-like brain damage as they age, and prior research shows these female mice tend to develop symptoms earlier and more severely than males, mirroring the pattern seen in human patients. Starting at three months old, before symptoms appeared, mice received either the vesicle treatment or a saltwater solution twice a week through the nose, continuing until they turned nine months old.

Along the way, mice took several classic memory tests: recognizing new objects, noticing when something in their environment moved, and navigating a maze that tests short-term memory. Treated mice outperformed untreated ones on the object-recognition and spatial-memory tests after both three and six months of treatment, and they also showed significantly better performance on the maze-navigation test after six months. Treatment even helped when started later, after disease-like changes had already set in, though the benefit showed up mainly in one test rather than all of them.

Alongside better memory, treated mice had far less of the sticky protein buildup called amyloid-beta in their hippocampus, with testing showing more than a 50 percent reduction. A separate hallmark of Alzheimer’s, the tangled protein called tau, showed no change, suggesting the vesicles target one piece of the disease rather than fixing everything at once.

Calming an Overactive Immune Response
Perhaps the most compelling part of the study involves what happened to the brain’s immune cells. Chronic activation of microglia and a related support cell called astrocytes is now considered a major driver of Alzheimer’s, not just a side effect of it. Treated mice had fewer of both cell types crowded into vulnerable brain regions, and the microglia that remained looked physically different, shifting away from the enlarged, hyper-branched shapes seen in the untreated Alzheimer’s mice toward simpler, less hypertrophic forms.

Markers that flag microglia as aggressively activated dropped after treatment, while markers tied to a calmer, repair-focused state rose sharply. Chemical signaling in the hippocampus shifted too, with several inflammation-promoting signals decreasing and protective ones increasing. Levels of proteins tied to healthy brain cell connections, including one called BDNF that helps neurons grow, also rose, hinting at a rebuilding process running alongside the calming effect.

To figure out what inside the vesicles actually caused this, researchers analyzed their cargo of microRNAs, tiny genetic snippets that act like dimmer switches for genes. The vesicles were packed with molecules already known to calm immune responses and support nerve health. When scientists stripped the vesicles of their RNA cargo and tested the emptied-out versions on inflamed microglia in a dish, the vesicles lost most of their calming power. That points to the RNA cargo, not just the vesicle’s outer shell, as the active ingredient.

From Mouse Brains to Human Alzheimer’s Neurons
A final piece of evidence came from human cells. Researchers took skin samples from people diagnosed with Alzheimer’s and from healthy volunteers of similar age, reprogrammed those cells into stem cells, and coaxed them into becoming brain cells. Neurons made from Alzheimer’s patients showed a well-documented problem: the branches that normally reach out to connect with other neurons started shrinking within about two weeks.

Adding the placenta-derived vesicles to these human cells during development largely prevented that shrinkage and restored levels of proteins needed for cell-to-cell communication, all without harming the cells. When researchers repeated the test with vesicles stripped of their RNA cargo, the protective effect weakened again, reinforcing that the genetic cargo drives the therapy’s power.

What This Could Mean for Future Alzheimer’s Treatment
Alzheimer’s has resisted decades of drug development, and much of that effort has centered on clearing amyloid rather than on the inflammation that keeps damaging the brain. This research adds to a growing case that the immune system inside the brain isn’t a bystander in this disease but an active participant that can potentially be coaxed back toward balance. A nasal spray built from placenta stem cell vesicles is still a long way from a pharmacy shelf, but the fact that it worked in both a mouse model and human brain cells taken from actual patients gives this approach two independent layers of evidence that are hard to dismiss.

Source: https://studyfinds.com/alzheimers-nasal-spray-made-from-placenta-stem-cells-protects-memory-calms-brain/

Previous Article
  • Research Discoveries

Americans Feel Mentally ‘Half Present’ 67 Days A Year. What’s Behind The Rut?

  • November 14, 2026
View Post
You May Also Like
View Post
  • Research Discoveries

Americans Feel Mentally ‘Half Present’ 67 Days A Year. What’s Behind The Rut?

  • November 14, 2026
View Post
  • Research Discoveries

Study Hints At Why Aging Bodies Run Cold

  • November 13, 2026
View Post
  • Research Discoveries

Forget Calorie Cuts? Food Quality May Be Key To Longer Life, Review Finds

  • November 12, 2026
View Post
  • Research Discoveries

AI Forecasts Heart Patients’ Survival Slightly Better Than Doctors

  • November 10, 2026
View Post
  • Research Discoveries

Teens Regularly Messaging ‘Online-Only’ Friends Report Lower Well-Being

  • November 6, 2026
View Post
  • Research Discoveries

A Common Cooking Oil Fat May Fuel Chronic Itch

  • November 5, 2026
View Post
  • Research Discoveries

The Belief About Death That’s Linked To Better Mental Health (It Isn’t Heaven)

  • November 5, 2026
View Post
  • Research Discoveries

More Vitamin C Pills In Pregnancy Linked To Calmer Babies

  • November 4, 2026

Recent Posts

  • Sonam Wangchuk raises alarm over minor; Ladakh Police says boy, mother safe
  • 24 terrorists, 4 soldiers killed in separate clashes in Pakistan’s Khyber Pakhtunkhwa, Balochistan
  • ‘Bharat Badnaam Summit’: BJP Attacks Rahul Gandhi Over Hyderabad Event, Accuses Him Of Defaming India
  • Delhi’s Air Quality Remains ‘Very Poor’ With AQI At 365, Multiple Areas Record Severe Pollution Levels
  • Microsoft’s Global Meltdown: How India’s Govt Digital Backbone Stayed Up & Running
Categories
  • Auto (43)
  • Business (474)
  • Climate & Earth (16)
  • Coronavirus (17)
  • Crypto (26)
  • Entertainment (894)
  • Happiness Basket (7)
  • India (6,356)
  • Learn | Unlearn | Relearn (163)
  • Lifestyle (334)
  • Politics (98)
  • Research Discoveries (455)
  • Science & Technology (469)
  • Sports (1,054)
  • Trending (1,803)
  • Video (1)
  • World (10,300)
Read Selective

For Feedbacks, Advertisements or Any Other Concerns mail us at info@readselective.com

Pages
  • Home
  • About US
  • Contact Us
  • Privacy Policy
  • Terms of Use
Categories
  • Auto
  • Business
  • Climate & Earth
  • Coronavirus
  • Crypto
  • Entertainment
  • Happiness Basket
  • India
  • Learn | Unlearn | Relearn
  • Lifestyle
  • Politics
  • Research Discoveries
  • Science & Technology
  • Sports
  • Trending
  • Video
  • World
© 2024 Read Selective | Developed by SUGARA Technologies
  • Home
  • About US
  • Contact Us
  • Privacy Policy
  • Terms of Use

Input your search keywords and press Enter.

Go to mobile version